Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geetha Srikrishna

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
The Lancet. Infectious Diseases|November 8, 2017
Genetics of human susceptibility to active and latent tuberculosis: present knowledge and future perspectivesLaurent Abel, Jacques Fellay, David W Haas, et al.
Nature Communications|December 9, 2023
Inhibition of host PARP1 contributes to the anti-inflammatory and antitubercular activity of pyrazinamideStefanie Krug, Manish Gupta, Pankaj Kumar, et al.
AIDS (London, England)|March 31, 2017
Intracellular HIV-1 RNA and CD4+ T-cell activation in patients starting antiretroviralsRamy El-Diwany, Florian P Breitwieser, Mary Soliman, et al.
Mbio|February 28, 2023
Adjunctive Integrated Stress Response Inhibition Accelerates Tuberculosis Clearance in MiceStefanie Krug, Pankaj Prasad, Shiqi Xiao, et al.
Carcinogenesis|August 12, 2008
RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesisOlga Turovskaya, Dirk Foell, Pratima Sinha, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
Gonadal regulation of sex-specific immunity in tuberculosis: enhanced lymphocyte function in females and dysfunctional myeloid responses in malesManish Gupta, Nishtha Nayyar, Jessica Shen, et al.
American Journal of Respiratory and Critical Care Medicine|April 25, 2013
Proinflammatory S100A12 can activate human monocytes via Toll-like receptor 4Dirk Foell, Helmut Wittkowski, Christoph Kessel, et al.
Biorxiv : the Preprint Server for Biology|January 3, 2024
Improved bladder cancer antitumor efficacy with a recombinant BCG that releases a STING agonistPeter K Um, Monali Praharaj, Kara A Lombardo, et al.
Nature Communications|March 24, 2026
Retraction Note: Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancerAlok Kumar Singh, Monali Praharaj, Kara A Lombardo, et al.
Nature Communications|February 16, 2022
Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancerAlok Kumar Singh, Monali Praharaj, Kara A Lombardo, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
The Lancet. Infectious Diseases|November 8, 2017
Genetics of human susceptibility to active and latent tuberculosis: present knowledge and future perspectivesLaurent Abel, Jacques Fellay, David W Haas, et al.
Nature Communications|December 9, 2023
Inhibition of host PARP1 contributes to the anti-inflammatory and antitubercular activity of pyrazinamideStefanie Krug, Manish Gupta, Pankaj Kumar, et al.
AIDS (London, England)|March 31, 2017
Intracellular HIV-1 RNA and CD4+ T-cell activation in patients starting antiretroviralsRamy El-Diwany, Florian P Breitwieser, Mary Soliman, et al.
Mbio|February 28, 2023
Adjunctive Integrated Stress Response Inhibition Accelerates Tuberculosis Clearance in MiceStefanie Krug, Pankaj Prasad, Shiqi Xiao, et al.
Carcinogenesis|August 12, 2008
RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesisOlga Turovskaya, Dirk Foell, Pratima Sinha, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
Gonadal regulation of sex-specific immunity in tuberculosis: enhanced lymphocyte function in females and dysfunctional myeloid responses in malesManish Gupta, Nishtha Nayyar, Jessica Shen, et al.
American Journal of Respiratory and Critical Care Medicine|April 25, 2013
Proinflammatory S100A12 can activate human monocytes via Toll-like receptor 4Dirk Foell, Helmut Wittkowski, Christoph Kessel, et al.
Biorxiv : the Preprint Server for Biology|January 3, 2024
Improved bladder cancer antitumor efficacy with a recombinant BCG that releases a STING agonistPeter K Um, Monali Praharaj, Kara A Lombardo, et al.
Nature Communications|March 24, 2026
Retraction Note: Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancerAlok Kumar Singh, Monali Praharaj, Kara A Lombardo, et al.
Nature Communications|February 16, 2022
Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancerAlok Kumar Singh, Monali Praharaj, Kara A Lombardo, et al.
Pageof 4